CIK: 1397607 - Address: C/o Precision Biosciences, Inc., 302 E. Pettigrew Street, Suite A-100, Durham, NC 27701
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11361410-3-23-38-6
P%wins100100100330056

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/6/21 18:00
5/4/21
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGATS-1,6962.950-575-77,675D
10/29/19 17:03
10/23/19
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGATP.m191.12017010,253D
5/14/18 16:01
5/10/18
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGADTM.d5001.900263310,237I
7/13/17 16:05
7/11/17
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGADTM.d800.047001,7071286,273D
9/6/16 16:15
9/1/16
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGADTP2,0000.410004,8782280,399I34-43-11-209132824802-8
3/17/16 16:05
3/15/16
COCPCocrystal Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSchinazi Raymond FGADTP1,5000.510002,9411275,521D11-40-10-10597-5025182-20
4/23/15 16:05
4/21/15
COCPCocrystal Pharma, Inc.NVHealthDrugPharmaceutical PreparationsSchinazi Raymond FWADTP3,1880.920023,4651272,580D203150150117-6-32-15-7111811-4-26-38
3/5/15 16:28
3/3/15
COCPCocrystal Pharma, Inc.NVHealthDrugPharmaceutical PreparationsSchinazi Raymond FWADTM.d00.002269,115New269,115D-656414476107361624206052-14-33

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact